Efficacy and safety in unresectable hepatocellular carcinoma with VP4 tumor embolus using sinilimab plus bevacizumab: A retrospective analysis of real-world evidence

被引：0
作者：
Cheng, Jiamin
Chen, Bowen
Zhang, Xinfeng
Su, Guodong
Peng, Caiyun
Lei, Jin
Yu, Lingxiang
Li, Yinyin
Lu, Yinying
机构：
[1] Peoples Liberat Army Gen Hosp, Senior Dept Hepatol, Med Ctr 5, Beijing, Peoples R China
[2] Peking Univ, Clin Med Sch 302, Beijing, Peoples R China
[3] Anhui Med Univ, Sch Clin Med 5, Hefei, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16156
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Early experience of atezolizumab plus bevacizumab therapy in Japanese patients with unresectable hepatocellular carcinoma in real-world practice
    Hayakawa, Yuka
    Tsuchiya, Kaoru
    Kurosaki, Masayuki
    Yasui, Yutaka
    Kaneko, Shun
    Tanaka, Yuki
    Ishido, Shun
    Inada, Kento
    Kirino, Sakura
    Yamashita, Koji
    Nobusawa, Tsubasa
    Matsumoto, Hiroaki
    Kakegawa, Tatsuya
    Higuchi, Mayu
    Takaura, Kenta
    Tanaka, Shohei
    Maeyashiki, Chiaki
    Tamaki, Nobuharu
    Nakanishi, Hiroyuki
    Itakura, Jun
    Takahashi, Yuka
    Asahina, Yasuhiro
    Okamoto, Ryuichi
    Izumi, Namiki
    [J]. INVESTIGATIONAL NEW DRUGS, 2022, 40 (02) : 392 - 402
  • [22] Early experience of atezolizumab plus bevacizumab therapy in Japanese patients with unresectable hepatocellular carcinoma in real-world practice
    Yuka Hayakawa
    Kaoru Tsuchiya
    Masayuki Kurosaki
    Yutaka Yasui
    Shun Kaneko
    Yuki Tanaka
    Shun Ishido
    Kento Inada
    Sakura Kirino
    Koji Yamashita
    Tsubasa Nobusawa
    Hiroaki Matsumoto
    Tatsuya Kakegawa
    Mayu Higuchi
    Kenta Takaura
    Shohei Tanaka
    Chiaki Maeyashiki
    Nobuharu Tamaki
    Hiroyuki Nakanishi
    Jun Itakura
    Yuka Takahashi
    Yasuhiro Asahina
    Ryuichi Okamoto
    Namiki Izumi
    [J]. Investigational New Drugs, 2022, 40 : 392 - 402
  • [23] Safety and efficacy of lenvatinib in patients with unresectable hepatocellular carcinoma (uHCC) in real-world practice in Korea
    Kang, W.
    Kim, J.
    Kim, S. U.
    Seo, Y-S.
    Kim, J.
    Kim, J-H.
    Park, S. Y.
    Baek, Y-H.
    Kim, K.
    Lee, H. L.
    Yoon, K. T.
    Kim, H.
    Cheong, J. Y.
    Hwang, J. S.
    Kim, J. H.
    Kim, K. M.
    Sung, P. S.
    Kim, J. J.
    Kim, D-Y.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S609 - S609
  • [24] Efficacy and safety of regorafenib combined with PD-1 inhibitors in patients with advanced hepatocellular beyond atezolizumab plus bevacizumab: A retrospective analysis of real-world evidence.
    Zhang, Xinfeng
    Cheng, Jiamin
    Chen, Bowen
    Zhang, Tianlan
    Li, Yinyin
    Zhang, Linzhi
    Dong, Jinghui
    Lu, Yinying
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [25] Upfront or add-on combination therapeutic strategy exploration in unresectable hepatocellular carcinoma using sorafenib plus sintilimab: A retrospective analysis of real-world evidence.
    Cheng, Jiamin
    Li, Yinyin
    Wu, Tong
    Zhang, Zhen
    Chen, Yan
    Su, Guodong
    Peng, Caiyun
    Zhang, Linzhi
    Lu, Yinying
    Zeng, Zhen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [26] Real-World Efficacy and Safety of Lenvatinib in Korean Patients with Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Analysis
    Cheon, Jaekyung
    Chon, Hong Jae
    Bang, Yeonghak
    Park, Neung Hwa
    Shin, Jung Woo
    Kim, Kang Mo
    Lee, Han Chu
    Lee, Jooho
    Yoo, Changhoon
    Ryoo, Baek-Yeol
    [J]. LIVER CANCER, 2020, 9 (05) : 613 - 624
  • [27] Real-world efficacy and safety of cabozantinib in Korean patients with advanced hepatocellular carcinoma: a multicenter retrospective analysis
    Bang, Yeong Hak
    Lee, Choong-kun
    Yoo, Changhoon
    Chon, Hong Jae
    Hong, Moonki
    Kang, Beodeul
    Kim, Hyung-Don
    Park, Sook Ryun
    Choi, Won-Mook
    Choi, Jonggi
    Lee, Danbi
    Shim, Ju Hyun
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Ryu, Min-Hee
    Ryoo, Baek-Yeol
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [28] Real-world efficacy and safety of lenvatinib in Korean patients with advanced hepatocellular carcinoma: A multicenter retrospective analysis
    Cheon, J.
    Yoo, C.
    Bang, Y.
    Chon, H.
    Ryoo, B-Y.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S1308 - S1308
  • [29] When will it be better? Lenvatinib combined with TACE for unresectable hepatocellular carcinoma: A retrospective analysis of real-world evidence in China.
    Zhang Lan
    Wang Yanhong
    Ge Ningling
    Gan Yu-Hong
    Ren ZhengGang
    Chen Yi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [30] Efficacy and safety of TACE combined with ablation and regorafenib for unresectable hepatocellular carcinoma: A real-world study.
    Xiong, Yiqi
    Gao, WenFeng
    Long, Jiang
    Hu, CaiXia
    Yuan, ChunWang
    Sun, Yu
    Shi, QinSheng
    Sun, Bin
    Zhang, YingHua
    Cui, XiongWei
    Hao, MeiJun
    Li, Jianjun
    Zhang, Yonghong
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345